Expand OPK Menu
OPK MENU

OPK Latest Press Releases

-- September 8, 2026 --

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference Globe Newswire 1:55 PM

-- August 13, 2026 --

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests Globe Newswire 9:15 AM

-- August 3, 2026 --

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health Globe Newswire 7:00 AM

-- July 27, 2026 --

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results Globe Newswire 4:05 PM

-- July 23, 2026 --

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026 Globe Newswire 12:30 PM

-- June 16, 2026 --

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026 Globe Newswire 8:33 AM

-- June 15, 2026 --

Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026 Globe Newswire 8:00 AM

-- May 12, 2026 --

OPKO Health's ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies Globe Newswire 8:00 AM

-- April 30, 2026 --

OPKO Health Expands Nicoya Agreement to Support RAYALDEE Commercialization in Greater China Globe Newswire 8:30 AM
BioReference Launches BioReference Direct , Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform Globe Newswire 8:00 AM

-- April 28, 2026 --

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results Globe Newswire 4:05 PM

-- April 22, 2026 --

OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas Globe Newswire 8:00 AM

-- April 21, 2026 --

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes